Ipca Laboratories Limited
IPCALAB
Classificação em ações
#3412
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Preço da ação
$20.02
Valor de mercado
$5.08B
Variação (1 dia)
-1.67%
Variação (1 ano)
37.00%
País
IN
Negociar Ipca Laboratories Limited (IPCALAB)
Categoria
Healthcare
EPS de Ipca Laboratories Limited (IPCALAB)
EPS em June 2026 TTM: $0.57
De acordo com os últimos relatórios financeiros e o preço das ações da Ipca Laboratories Limited, o EPS atual da empresa (TTM) é $0.57. No final de 2024, a empresa teve um EPS de $0.26, um aumento em relação a ao EPS de 2023, que foi de $0.23.
Histórico de EPS da Ipca Laboratories Limited de 2005 até 2026
EPS no final de cada ano
| Ano | EPS | Alterar |
|---|---|---|
| 2026 (TTM) | $0.57 | 67.59% |
| 2025 | $0.34 | 31.43% |
| 2024 | $0.26 | 14.42% |
| 2023 | $0.23 | -50.75% |
| 2022 | $0.46 | -25.34% |
| 2021 | $0.61 | 93.12% |
| 2020 | $0.32 | 25.55% |
| 2019 | $0.25 | 73.94% |
| 2018 | $0.15 | 22.62% |
| 2017 | $0.12 | 113.46% |
| 2016 | $0.06 | -65.49% |
| 2015 | $0.16 | -48.97% |
| 2014 | $0.32 | 34.08% |
| 2013 | $0.24 | 8.86% |
| 2012 | $0.22 | -7.87% |
| 2011 | $0.24 | 28.52% |
| 2010 | $0.18 | 131.65% |
| 2009 | $0.08 | -41.78% |
| 2008 | $0.14 | 16.48% |
| 2007 | $0.12 | 111.05% |
| 2006 | $0.06 | -18.58% |
| 2005 | $0.07 | 0.00% |
EPS de empresas semelhantes ou concorrentes
| Empresa | EPS | Diferença de EPS | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -2.37% |
IN
|
